IC-13 Anti-Angiogenesis in Modern Times

Course Organiser: U. Schmidt-Erfurth AUSTRIA


U. Schmidt-Erfurth AUSTRIA 
Brolucizumab: A novel player on the horizon

D. Martin USA 
How to choose the right anti-VEGF therapy in AMD

N. Waheed USA
Evaluating the therapeutic response of CNV by OCT-A

A. Loewenstein ISRAEL
A state-of-the-art in anti-VEGF in diabetic retinopathy

P. Dugel USA
Anti-angiopoetin: A new non-VEGF concept in AMD and DME



End of course

Book your Course Ticket here and select ‘Add another registration package’



Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait